Sgmo stock price movement is being closely correlated

sgmo stock price movement is being closely correlated with peer performance in the gene therapy niche. Cross-comparison models show Sangamo lagging average sector returns by 3% over the past month. If you want to know who really controls Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 55% to be precise, is institutions. In other words, the group stands to gain the most (or lose the most) from their investment into the company. Sangamo Therapeutics SGMO stock crashed 60.4% after hours on Monday after it announced that its partner, Pfizer PFE , terminated its global collaboration and license agreement for giroctocogene fitelparvovec, a one-time gene therapy candidate for treating moderately severe to severe hemophilia A. Hedge fund positioning reports imply cautious optimism on sgmo stock price, with mixed bets on short-term downside and long-term turnaround fueled by trial successes.